Twist Bioscience insider files to sell 124 vested shares on 10/02/2025
Rhea-AI Filing Summary
Form 144 notice for Twist Bioscience Corp (TWST) shows an officer or insider, Dennis H. Cho, proposing to sell 124 common shares on 10/02/2025. Those 124 shares were acquired the prior day, 10/01/2025, by restricted stock vesting as compensation. The filing lists the broker as Fidelity Brokerage Services LLC and indicates an aggregate market value of $3,615.95 for the shares to be sold. The issuer has 60,360,925 shares outstanding per the form. The filing also discloses six prior open-market sales by Dennis H. Cho from 07/02/2025 through 09/22/2025, totaling 2,027 shares and gross proceeds of $54,048.04 across those transactions. The filer certifies no undisclosed material adverse information.
Positive
- Full disclosure of acquisition method (restricted stock vesting) and sale dates
- Broker identified (Fidelity Brokerage Services LLC) and aggregate market value provided
- Prior sales listed with dates and gross proceeds totaling $54,048.04
Negative
- Insider selling shares (2,027 shares sold in the past three months plus 124 proposed sale)
- Proposed sale of newly vested shares on 10/02/2025 may increase free float
Insights
Insider sold newly vested shares and previously sold 2,027 shares this quarter.
The filing documents a small planned sale of 124 shares arising from restricted stock vesting on 10/01/2025, to be executed through Fidelity on 10/02/2025. The insider previously sold 2,027 shares between 07/02/2025 and 09/22/2025 for total gross proceeds of $54,048.04, which is fully disclosed in the form.
This is a routine disclosure under Rule 144 and the signer attests there is no undisclosed material adverse information.